Skip to main content

Psychedelic Integration: Premise & Promise | On-Demand

Fluence’s foundational course is designed for those who want to learn about Psychedelic Harm Reduction and Integration Therapy in clinical practice.


Dr. Elizabeth Nielson
Dr. Ingmar Gorman


$395 Includes 6 hours of APA CE and NYSED CE for Psychologists, Social Workers, and LMHCs

Course Description

Learning Objectives

At the end of this course, the participant will be able to:

  • Name one early model of psychedelic therapy that informs modern clinical research with psilocybin
  • Identify at least 3 indications for which psilocybin-assisted therapy has been researched in modern clinical trials
  • Name at least two key figures in modern clinical research with MDMA
  • Explain one reason why MDMA-assisted therapy is thought to be a good fit for treatment of PTSD
  • Explain how current MDMA-assisted therapy combines non-drug psychotherapy sessions with MDMA sessions
  • Discuss the historical justifications for psychedelic clinical research
  • Describe key theoretical approaches to psychedelic-assisted therapy
  • Discuss the state of psychedelic clinical research, rescheduling efforts, and how psychedelic-assisted psychotherapy works with clients
  • Compare psychedelic integration psychotherapy to integration in peer and shamanic settings
  • List key “red flags” that indicate someone should seek specialized psychiatric care after a psychedelic experience
  • List principles of psychedelic-assisted therapy in a basic/initial assessment of clients who report psychedelic use
  • List contraindications and discuss high risk cases of individuals who are contemplating psychedelic use
  • Describe the role of the therapist in an individual's integration psychotherapy process
start now
information for medical professionals and about CEs

Other Dates for this Course

Upcoming Events

Other Upcoming Courses

Thanks for signing up for our newsletter!
please enter a valid email address.